1.
Baricitinib for hospitalised COVID-19 patients: was it a good and timely decision made by the Ministry of Health Malaysia? High-quality evidence-based editorial. Int. Med. Res. J. 2026;10(1). Accessed October 23, 2026. https://journal.nih.gov.my/index.php/imrj/article/view/157